You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pabolizumab

Showing 1 - 2 of 2
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced

Recruiting
  • Gastric Cancer
  • Gastric Adenocarcinoma
  • pabolizumab
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Apr 4, 2023

NSCLC Patients Trial in Shanghai (pabolizumab, nafulizumab)

Recruiting
  • NSCLC Patients
  • Shanghai, Shanghai, China
    Cancer hospital Fudan University
Jun 9, 2020